Yu-Fei Qiu , Ji-Sheng Hu , Man Wu , Jia-Li Liu , Chao-Yang Li , Yi-Qing Yu , Li-Juan Zeng , Fen Yang , Lan Zheng
{"title":"远程干预对慢性阻塞性肺病(COPD)患者抑郁和焦虑症状的影响:系统回顾与荟萃分析","authors":"Yu-Fei Qiu , Ji-Sheng Hu , Man Wu , Jia-Li Liu , Chao-Yang Li , Yi-Qing Yu , Li-Juan Zeng , Fen Yang , Lan Zheng","doi":"10.1016/j.genhosppsych.2024.10.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Depression and anxiety are common psychiatric symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD). While face-to-face psychotherapy is a common option, tele-based interventions provide a more accessible alternative. However, a comprehensive synthesis of evidence from clinical trials for COPD patients has yet to be conducted.</div></div><div><h3>Objective</h3><div>This study aims to evaluate the effects of tele-based interventions in reducing depressive and anxiety symptoms in patients with COPD.</div></div><div><h3>Methods</h3><div>A systematic search of PubMed, EMBASE, the Cochrane Library, Web of Science, PsycINFO, and MEDLINE databases was conducted from inception to May 5, 2024. Eligible studies included Randomized Controlled Trials (RCTs) of people with COPD patients receiving tele-based interventions reporting on the outcomes of depression or anxiety. Data extraction and quality assessment were performed independently by two researchers. The quality of the included studies was assessed using the Cochrane risk-of-bias tool. Meta-analysis was performed using RevMan (version 5.4) and Stata (version 18.0) software.</div></div><div><h3>Results</h3><div>Following the search, 9 RCTs with a total of 2064 patients with COPD were included. The meta-analysis revealed that tele-based interventions reduced depressive symptoms in patients with COPD (Standardized Mean Difference [SMD] = −0.15, 95 % CI −0.24 to −0.06; <em>P</em> = 0.001). The subgroup analysis indicated that the PHQ-9 (SMD = −0.24, 95 % CI −0.37 to −0.10; <em>P =</em> 0.001) was better at detecting changes in depressive symptoms compared to other scales; the first 3 months of intervention (SMD = −0.36, 95 % CI −0.52 to −0.19; <em>P</em> <em><</em> 0.001) was the most pronounced improvement; and telehealth interventions were more effective (SMD = −0.30, 95 % CI −0.46 to −0.15; <em>P <</em> 0.001) than telemonitoring interventions. Tele-based interventions also reduced anxiety symptoms in patients with COPD (SMD = −0.12, 95 % CI −0.22 to −0.02; <em>P</em> = 0.02).</div></div><div><h3>Conclusions</h3><div>The evidence supports the efficacy of tele-based interventions in alleviating depression and anxiety symptoms in COPD patients. However, further large-scale and rigorously designed studies are warranted to strengthen the evidence.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"91 ","pages":"Pages 143-150"},"PeriodicalIF":4.1000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effects of tele-based interventions for depression and anxiety symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD): A systematic review and meta-analysis\",\"authors\":\"Yu-Fei Qiu , Ji-Sheng Hu , Man Wu , Jia-Li Liu , Chao-Yang Li , Yi-Qing Yu , Li-Juan Zeng , Fen Yang , Lan Zheng\",\"doi\":\"10.1016/j.genhosppsych.2024.10.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Depression and anxiety are common psychiatric symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD). While face-to-face psychotherapy is a common option, tele-based interventions provide a more accessible alternative. However, a comprehensive synthesis of evidence from clinical trials for COPD patients has yet to be conducted.</div></div><div><h3>Objective</h3><div>This study aims to evaluate the effects of tele-based interventions in reducing depressive and anxiety symptoms in patients with COPD.</div></div><div><h3>Methods</h3><div>A systematic search of PubMed, EMBASE, the Cochrane Library, Web of Science, PsycINFO, and MEDLINE databases was conducted from inception to May 5, 2024. Eligible studies included Randomized Controlled Trials (RCTs) of people with COPD patients receiving tele-based interventions reporting on the outcomes of depression or anxiety. Data extraction and quality assessment were performed independently by two researchers. The quality of the included studies was assessed using the Cochrane risk-of-bias tool. Meta-analysis was performed using RevMan (version 5.4) and Stata (version 18.0) software.</div></div><div><h3>Results</h3><div>Following the search, 9 RCTs with a total of 2064 patients with COPD were included. The meta-analysis revealed that tele-based interventions reduced depressive symptoms in patients with COPD (Standardized Mean Difference [SMD] = −0.15, 95 % CI −0.24 to −0.06; <em>P</em> = 0.001). The subgroup analysis indicated that the PHQ-9 (SMD = −0.24, 95 % CI −0.37 to −0.10; <em>P =</em> 0.001) was better at detecting changes in depressive symptoms compared to other scales; the first 3 months of intervention (SMD = −0.36, 95 % CI −0.52 to −0.19; <em>P</em> <em><</em> 0.001) was the most pronounced improvement; and telehealth interventions were more effective (SMD = −0.30, 95 % CI −0.46 to −0.15; <em>P <</em> 0.001) than telemonitoring interventions. Tele-based interventions also reduced anxiety symptoms in patients with COPD (SMD = −0.12, 95 % CI −0.22 to −0.02; <em>P</em> = 0.02).</div></div><div><h3>Conclusions</h3><div>The evidence supports the efficacy of tele-based interventions in alleviating depression and anxiety symptoms in COPD patients. However, further large-scale and rigorously designed studies are warranted to strengthen the evidence.</div></div>\",\"PeriodicalId\":12517,\"journal\":{\"name\":\"General hospital psychiatry\",\"volume\":\"91 \",\"pages\":\"Pages 143-150\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"General hospital psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0163834324002196\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"General hospital psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163834324002196","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
背景抑郁和焦虑是慢性阻塞性肺病(COPD)患者常见的精神症状。虽然面对面的心理治疗是一种常见的选择,但远程干预提供了一种更方便的替代方法。本研究旨在评估远程干预在减轻慢性阻塞性肺病患者抑郁和焦虑症状方面的效果。方法对 PubMed、EMBASE、Cochrane Library、Web of Science、PsycINFO 和 MEDLINE 数据库进行了系统检索,检索时间从开始到 2024 年 5 月 5 日。符合条件的研究包括慢性阻塞性肺病患者接受远程干预的随机对照试验(RCT),报告了抑郁或焦虑的结果。数据提取和质量评估由两名研究人员独立完成。纳入研究的质量采用 Cochrane 偏倚风险工具进行评估。使用 RevMan(5.4 版)和 Stata(18.0 版)软件进行了荟萃分析。荟萃分析表明,远程干预可减轻慢性阻塞性肺病患者的抑郁症状(标准化平均差 [SMD] = -0.15,95 % CI -0.24 至 -0.06;P = 0.001)。亚组分析表明,与其他量表相比,PHQ-9(SMD = -0.24,95 % CI -0.37 to -0.10;P = 0.001)更能检测出抑郁症状的变化;干预的前 3 个月(SMD = -0.36,95 % CI -0.52 to -0.19;P <;0.001)是最明显的改善;远程健康干预比远程监测干预更有效(SMD = -0.30,95 % CI -0.46 to -0.15;P <;0.001)。远程干预还能减轻慢性阻塞性肺病患者的焦虑症状(SMD = -0.12,95 % CI -0.22 to -0.02;P = 0.02)。结论有证据表明,远程干预能有效减轻慢性阻塞性肺病患者的抑郁和焦虑症状。然而,还需要进一步开展大规模和严格设计的研究,以加强证据。
The effects of tele-based interventions for depression and anxiety symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD): A systematic review and meta-analysis
Background
Depression and anxiety are common psychiatric symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD). While face-to-face psychotherapy is a common option, tele-based interventions provide a more accessible alternative. However, a comprehensive synthesis of evidence from clinical trials for COPD patients has yet to be conducted.
Objective
This study aims to evaluate the effects of tele-based interventions in reducing depressive and anxiety symptoms in patients with COPD.
Methods
A systematic search of PubMed, EMBASE, the Cochrane Library, Web of Science, PsycINFO, and MEDLINE databases was conducted from inception to May 5, 2024. Eligible studies included Randomized Controlled Trials (RCTs) of people with COPD patients receiving tele-based interventions reporting on the outcomes of depression or anxiety. Data extraction and quality assessment were performed independently by two researchers. The quality of the included studies was assessed using the Cochrane risk-of-bias tool. Meta-analysis was performed using RevMan (version 5.4) and Stata (version 18.0) software.
Results
Following the search, 9 RCTs with a total of 2064 patients with COPD were included. The meta-analysis revealed that tele-based interventions reduced depressive symptoms in patients with COPD (Standardized Mean Difference [SMD] = −0.15, 95 % CI −0.24 to −0.06; P = 0.001). The subgroup analysis indicated that the PHQ-9 (SMD = −0.24, 95 % CI −0.37 to −0.10; P = 0.001) was better at detecting changes in depressive symptoms compared to other scales; the first 3 months of intervention (SMD = −0.36, 95 % CI −0.52 to −0.19; P< 0.001) was the most pronounced improvement; and telehealth interventions were more effective (SMD = −0.30, 95 % CI −0.46 to −0.15; P < 0.001) than telemonitoring interventions. Tele-based interventions also reduced anxiety symptoms in patients with COPD (SMD = −0.12, 95 % CI −0.22 to −0.02; P = 0.02).
Conclusions
The evidence supports the efficacy of tele-based interventions in alleviating depression and anxiety symptoms in COPD patients. However, further large-scale and rigorously designed studies are warranted to strengthen the evidence.
期刊介绍:
General Hospital Psychiatry explores the many linkages among psychiatry, medicine, and primary care. In emphasizing a biopsychosocial approach to illness and health, the journal provides a forum for professionals with clinical, academic, and research interests in psychiatry''s role in the mainstream of medicine.